National Research (NASDAQ:NRC) Stock Passes Above 200 Day Moving Average – Here’s Why

National Research Corporation (NASDAQ:NRC) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $17.16 and traded as high as $19.68. National Research shares last traded at $19.04, with a volume of 75,438 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings cut National Research from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, March 6th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.

National Research Stock Down 1.1%

The stock has a 50 day simple moving average of $17.59 and a 200-day simple moving average of $17.16. The firm has a market cap of $433.16 million, a PE ratio of 48.82 and a beta of 0.31. The company has a debt-to-equity ratio of 5.48, a current ratio of 0.52 and a quick ratio of 0.52.

National Research (NASDAQ:NRC) last announced its quarterly earnings data on Tuesday, April 28th. The company reported $0.21 earnings per share (EPS) for the quarter. The business had revenue of $34.80 million during the quarter. National Research had a return on equity of 122.73% and a net margin of 6.52%.

National Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 10th. Shareholders of record on Friday, June 26th will be paid a dividend of $0.16 per share. The ex-dividend date is Friday, June 26th. This represents a $0.64 dividend on an annualized basis and a yield of 3.4%. National Research’s payout ratio is presently 164.10%.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Quantinno Capital Management LP increased its position in National Research by 61.3% during the first quarter. Quantinno Capital Management LP now owns 62,329 shares of the company’s stock valued at $1,058,000 after acquiring an additional 23,682 shares during the last quarter. Empowered Funds LLC purchased a new stake in National Research during the first quarter valued at $226,000. Bank of New York Mellon Corp increased its position in National Research by 4.0% during the first quarter. Bank of New York Mellon Corp now owns 250,707 shares of the company’s stock valued at $4,257,000 after acquiring an additional 9,730 shares during the last quarter. Hsbc Holdings PLC purchased a new stake in National Research during the first quarter valued at $180,000. Finally, Fifth Third Bancorp purchased a new stake in National Research during the first quarter valued at $1,531,000. Hedge funds and other institutional investors own 47.26% of the company’s stock.

National Research Company Profile

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.